Skip to content
Elderly AML & Burkitt Lymphoma Updates episode artwork

Nov 9, 2023 24 min

Elderly AML & Burkitt Lymphoma Updates

from OncoPharm Hosted by John Bossaer

Aggressive hematologic malignancy publications can be challenging to interpret and translate to clinical practice. We look at two recent studies to illustrate this point. Elderly AML: 10-day decitabine vs. 7 + 3 (https://doi.org/10.1016/S2352-3026(23)00273-9) Burkitt Lymphoma: R-CODXO-M/R-IVAC vs. DA-R-EPOCH (https://doi.org/10.1016/S2352-3026(23)00279-X)

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Elderly AML & Burkitt Lymphoma Updates

0:00 24:39

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 24 minutes long.

When was this OncoPharm episode published?

This episode was published on November 9, 2023.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.